MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-07-2025
National Research Corporation P/S Ratio 2011-2026 | NRC
Annual P/S Ratio National Research Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.79 | 7.51 | 7.15 | 8.51 | 13.4 | 8.88 | 7.64 | 3.81 | 3.57 | 3.4 | 4.04 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.4 | 3.4 | 6.79 |
P/S Ratio of other stocks in the Diagnostics research industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
1.72 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
0.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
5.55 | - | -6.19 % | $ 10.5 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
6.87 | $ 33.55 | -1.5 % | $ 377 M |  China |
 |
Brainsway Ltd.
BWAY
|
8.09 | $ 23.55 | 0.73 % | $ 99.4 M |  Israel |
 |
Biocept
BIOC
|
0.229 | - | -13.05 % | $ 7.29 M | USA |
 |
Accelerate Diagnostics
AXDX
|
13.5 | - | -61.36 % | $ 2.46 M | USA |
 |
BioNano Genomics
BNGO
|
0.115 | $ 1.27 | -1.92 % | $ 1.61 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
5.71 | - | - | $ 562 M |  Britain |
 |
Chembio Diagnostics
CEMI
|
0.254 | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
2.14 | $ 40.56 | 2.97 % | $ 1.13 B | USA |
 |
Co-Diagnostics
CODX
|
5.13 | - | - | $ 79.8 M | USA |
 |
Danaher Corporation
DHR
|
6.37 | $ 218.21 | -0.31 % | $ 160 B | USA |
 |
DermTech
DMTK
|
2.77 | - | -11.32 % | $ 2.94 M | USA |
 |
Global Cord Blood Corporation
CO
|
0.196 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
3.48 | - | 1.08 % | $ 308 M | USA |
 |
Exact Sciences Corporation
EXAS
|
3.38 | $ 102.48 | 0.14 % | $ 19 B | USA |
 |
Genetic Technologies Limited
GENE
|
1.36 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
2.9 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
2.47 | - | - | $ 10.7 B | USA |
 |
DexCom
DXCM
|
13.5 | $ 73.22 | 0.25 % | $ 28.3 B | USA |
 |
CareDx, Inc
CDNA
|
1.86 | $ 21.0 | 2.19 % | $ 1.13 B | USA |
 |
Guardant Health
GH
|
7.91 | $ 114.82 | 0.68 % | $ 14.1 B | USA |
 |
DarioHealth Corp.
DRIO
|
2.13 | $ 10.2 | 1.8 % | $ 289 M | Israel |
 |
Enzo Biochem
ENZ
|
0.0018 | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
1.65 | $ 26.24 | 0.15 % | $ 793 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
0.469 | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
3.28 | - | - | $ 1.31 B | USA |
 |
IDEXX Laboratories
IDXX
|
9.66 | $ 643.58 | -4.01 % | $ 53.1 B | USA |
 |
Illumina
ILMN
|
3.75 | $ 142.0 | -1.94 % | $ 22.6 B | USA |
 |
QIAGEN N.V.
QGEN
|
5.03 | - | - | $ 10.6 B |  Niderland |
 |
Lantheus Holdings
LNTH
|
4.21 | $ 67.41 | 0.73 % | $ 4.66 B | USA |
 |
IQVIA Holdings
IQV
|
2.31 | $ 229.9 | -0.11 % | $ 41.7 B | USA |
 |
Medpace Holdings
MEDP
|
4.83 | $ 589.59 | 1.22 % | $ 18.3 B | USA |
 |
Charles River Laboratories International
CRL
|
2.11 | $ 210.66 | 0.04 % | $ 10.8 B | USA |
 |
NeoGenomics
NEO
|
2.31 | $ 12.17 | 0.79 % | $ 1.54 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.93 | $ 183.26 | -1.98 % | $ 20.3 B | USA |
|
Biodesix
BDSX
|
1.29 | $ 9.32 | -8.36 % | $ 1.21 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
1.8 | $ 28.72 | 0.05 % | $ 20 B | Niderland |
 |
Precipio
PRPO
|
0.572 | $ 24.54 | 0.04 % | $ 31.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.62 | $ 266.32 | -1.91 % | $ 22.3 B | USA |
 |
Personalis
PSNL
|
3 | $ 9.43 | 0.59 % | $ 559 M | USA |
 |
ICON Public Limited Company
ICLR
|
3.25 | $ 180.05 | -0.11 % | $ 14.9 B |  Irlanda |
 |
Agilent Technologies
A
|
6.64 | $ 133.97 | 0.07 % | $ 40.7 B | USA |
 |
Biomerica
BMRA
|
1.35 | $ 2.38 | - | $ 5.47 M | USA |
 |
OpGen
OPGN
|
1.76 | - | -16.95 % | $ 1.54 M | USA |
 |
Bioventus
BVS
|
0.685 | $ 8.16 | 2.9 % | $ 511 M | USA |